Walleye Capital’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Sell |
29,948
-11,524
| -28% | -$108K | ﹤0.01% | 1262 |
|
|
2025
Q1 | $295K | Sell |
41,472
-142,600
| -77% | -$1.01M | ﹤0.01% | 1270 |
|
|
2024
Q4 | $2.15M | Buy |
184,072
+113,043
| +159% | +$1.32M | 0.01% | 680 |
|
|
2024
Q3 | $1.46M | Buy |
71,029
+15,874
| +29% | +$326K | ﹤0.01% | 893 |
|
|
2024
Q2 | $1.23M | Buy |
55,155
+49,647
| +901% | +$1.11M | ﹤0.01% | 1025 |
|
|
2024
Q1 | $152K | Sell |
5,508
-197,819
| -97% | -$5.44M | ﹤0.01% | 1899 |
|
|
2023
Q4 | $6.2M | Buy |
203,327
+19,872
| +11% | +$606K | 0.01% | 301 |
|
|
2023
Q3 | $5.8M | Buy |
+183,455
| New | +$5.8M | 0.01% | 341 |
|
|
2023
Q2 | – | Sell |
-127,504
| Closed | -$4.75M | – | 2610 |
|
|
2023
Q1 | $4.75M | Buy |
127,504
+32,080
| +34% | +$1.2M | 0.07% | 304 |
|
|
2022
Q4 | $3.33M | Buy |
95,424
+77,163
| +423% | +$2.69M | 0.06% | 343 |
|
|
2022
Q3 | $1.02M | Buy |
+18,261
| New | +$1.02M | 0.02% | 710 |
|
|
2022
Q2 | – | Sell |
-50,521
| Closed | -$3.67M | – | 2552 |
|
|
2022
Q1 | $3.67M | Buy |
50,521
+43,147
| +585% | +$3.14M | 0.1% | 208 |
|
|
2021
Q4 | $872K | Buy |
+7,374
| New | +$872K | 0.03% | 658 |
|
|
2020
Q2 | – | Sell |
-1,485
| Closed | -$18K | – | 730 |
|
|
2020
Q1 | $18K | Sell |
1,485
-1,112
| -43% | -$13.5K | ﹤0.01% | 457 |
|
|
2019
Q4 | $38K | Sell |
2,597
-924
| -26% | -$13.5K | ﹤0.01% | 539 |
|
|
2019
Q3 | $47K | Buy |
+3,521
| New | +$47K | ﹤0.01% | 357 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 768 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 530 |
|